What is it about?

Evidenced based practice is important when providing care for babies and their families. There is a paucity of evidence about normal blood concentrations in healthy babies, and this in part is because of reluctance to undertake invasive testing in healthy newborn babies. The Glucose in Well Babies (GLOW) study sought to describe blood glucose, lactate and ketones in healthy babies over the first five postnatal days. We sought to understand both parents experience of participation in this study, which required heel-prick blood samples, continuous glucose monitoring, twice daily home visits and parents were asked to record all feeds. Our findings show that parents report a positive experience of having their newborn baby participate in a moderately invasive clinical study. Therefore, our findings provide important reassurance to parents, clinicians, researchers and ethics committees that invasive non-therapeutic clinical studies are feasible in newborn babies and can be acceptable to parents.

Featured Image

Why is it important?

Our findings provide important reassurance to parents, clinicians, researchers and ethics committees that invasive non-therapeutic clinical studies are feasible in newborn babies and can be acceptable to parents.

Read the Original

This page is a summary of: Parents of babies who participated in an invasive clinical study report a positive experience: the Glucose in Well Babies (GLOW) study, Archives of Disease in Childhood Fetal & Neonatal, October 2019, BMJ,
DOI: 10.1136/archdischild-2019-317417.
You can read the full text:

Read

Contributors

The following have contributed to this page